Current options for the treatment of resistant hypertension.

about

Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management.

P2860

Q38083010-78476222-260E-4FCB-BD6E-5BD991D5EB0B

P2860

Current options for the treatment of resistant hypertension.

Item

http://www.wikidata.org/entity/Q37629838

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Current options for the treatment of resistant hypertension.

@en

Current options for the treatment of resistant hypertension.

@nl

type

Item

label

Current options for the treatment of resistant hypertension.

@en

Current options for the treatment of resistant hypertension.

@nl

prefLabel

Current options for the treatment of resistant hypertension.

@en

Current options for the treatment of resistant hypertension.

@nl

P1476

Current options for the treatment of resistant hypertension.

@en

P2093

David A Calhoun

http://www.w3.org/2001/XMLSchema#string

Mustafa I Ahmed

http://www.w3.org/2001/XMLSchema#string

Roberto Pisoni

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Non-narcotic analgesic dose and risk of incident hypertension in US women

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

Prospective study of the association between sleep-disordered breathing and hypertension

Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Is resistant hypertension really resistant?

Renal-artery stenosis.

P304

1385-1393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERC.09.120

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19900021

http://www.w3.org/2001/XMLSchema#string

Current options for the treatment of resistant hypertension.

about

P2860

P2860

Current options for the treatment of resistant hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698